Aytu BioPharma 
Welcome,         Profile    Billing    Logout  
 5 Products   134 Diseases  5 Products   3 Trials   544 News 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kinenza (enzastaurin) / Denovo, Aytu BioPharma
ENGAGE, NCT03776071: A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Completed
3
260
Canada, US, RoW
Enzastaurin Hydrochloride, Kinenza, Placebo, Temozolomide, Temodar, Radiotherapy
Denovo Biopharma LLC
Glioblastoma
02/24
02/24
2006-004486-34: An Open-Label Study of Oral Enzastaurin HCI in Patients with Advanced or Metastatic Malignancies

Ongoing
2
3
Europe
Enzastaurin, LY317615,
Eli Lilly and Company limited
Have a histologic or cytologic diagnosis of advanced or metastatic malignancies for which no life-prolonging therapy exists and have been previously enrolled and completed therapy in an enzastaurin clinical pharmacology and biopharmaceutics study.
 
 
Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
NCT04976595: A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Recruiting
4
218
US
Natesto, Testosterone Nasal Gel
Acerus Pharmaceuticals Corporation
Hypogonadism
12/22
12/22
NCT05381831: Natesto Spermatogenesis Reboot

Completed
4
13
US
NatestoTM
University of Florida, Acerus Pharmaceutical
Hypogonadism, Male
04/25
04/25
NCT04439799: A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Completed
4
81
US
Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone, Natesto
University of Miami, Acerus Pharmaceuticals Corporation
Hypogonadism, Male
02/23
02/23
2017-001012-11: A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys

Not yet recruiting
1
20
Europe
Natesto™/TBS-1, Natesto™, Nasal gel, Natesto®
Acerus Biopharma Inc., Acerus Biopharma Inc.
Primary and secondary hypogonadism, Primary and secondary hypogonadism, Body processes [G] - Biological Phenomena [G16]
 
 
NCT06130449: Testosterone and Neural Function

Recruiting
1
15
US
Natesto testosterone intranasal gel, testosterone intranasal gel, Ayr Saline Nasal Gel, Saline Nasal Gel
VA Office of Research and Development
Spinal Cord Injury
12/25
03/26
NCT04717362: The Effects of Natesto For Treatment Of Hypogonadism

Withdrawn
1
40
NA
Natesto Nasal Product
Baylor College of Medicine
Hypogonadism, Male, Infertility, Male, Testosterone Deficiency
12/24
12/24
Zolpimist (zolpidem oral spray) / Arovella Therap, Aytu BioPharma
NCT03657212: Enhancing Memory Consolidation in Older Adults

Terminated
4
10
US
Zolpidem, Ambien, Edluar, Zolpimist
University of California, Irvine
Aging
01/19
01/19
NCT03436745: The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Completed
1
12
US
Zolpidem, Ambien, Zolpimist, Edluar, ECG, Electrocardiogram
National Cancer Institute (NCI)
Prostatic Neoplasms
01/24
01/24
Tuzistra XR (codeine/chlorpheniramine) / Tris Pharma, Aytu BioPharma, HitGen
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kinenza (enzastaurin) / Denovo, Aytu BioPharma
ENGAGE, NCT03776071: A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Completed
3
260
Canada, US, RoW
Enzastaurin Hydrochloride, Kinenza, Placebo, Temozolomide, Temodar, Radiotherapy
Denovo Biopharma LLC
Glioblastoma
02/24
02/24
2006-004486-34: An Open-Label Study of Oral Enzastaurin HCI in Patients with Advanced or Metastatic Malignancies

Ongoing
2
3
Europe
Enzastaurin, LY317615,
Eli Lilly and Company limited
Have a histologic or cytologic diagnosis of advanced or metastatic malignancies for which no life-prolonging therapy exists and have been previously enrolled and completed therapy in an enzastaurin clinical pharmacology and biopharmaceutics study.
 
 
Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
NCT04976595: A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Recruiting
4
218
US
Natesto, Testosterone Nasal Gel
Acerus Pharmaceuticals Corporation
Hypogonadism
12/22
12/22
NCT05381831: Natesto Spermatogenesis Reboot

Completed
4
13
US
NatestoTM
University of Florida, Acerus Pharmaceutical
Hypogonadism, Male
04/25
04/25
NCT04439799: A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Completed
4
81
US
Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone, Natesto
University of Miami, Acerus Pharmaceuticals Corporation
Hypogonadism, Male
02/23
02/23
2017-001012-11: A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys

Not yet recruiting
1
20
Europe
Natesto™/TBS-1, Natesto™, Nasal gel, Natesto®
Acerus Biopharma Inc., Acerus Biopharma Inc.
Primary and secondary hypogonadism, Primary and secondary hypogonadism, Body processes [G] - Biological Phenomena [G16]
 
 
NCT06130449: Testosterone and Neural Function

Recruiting
1
15
US
Natesto testosterone intranasal gel, testosterone intranasal gel, Ayr Saline Nasal Gel, Saline Nasal Gel
VA Office of Research and Development
Spinal Cord Injury
12/25
03/26
NCT04717362: The Effects of Natesto For Treatment Of Hypogonadism

Withdrawn
1
40
NA
Natesto Nasal Product
Baylor College of Medicine
Hypogonadism, Male, Infertility, Male, Testosterone Deficiency
12/24
12/24
Zolpimist (zolpidem oral spray) / Arovella Therap, Aytu BioPharma
NCT03657212: Enhancing Memory Consolidation in Older Adults

Terminated
4
10
US
Zolpidem, Ambien, Edluar, Zolpimist
University of California, Irvine
Aging
01/19
01/19
NCT03436745: The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Completed
1
12
US
Zolpidem, Ambien, Zolpimist, Edluar, ECG, Electrocardiogram
National Cancer Institute (NCI)
Prostatic Neoplasms
01/24
01/24
Tuzistra XR (codeine/chlorpheniramine) / Tris Pharma, Aytu BioPharma, HitGen
No trials found

Download Options